Answers are grounded in this paper and cite their sources.
The lack of universal markers for extracellular vesicles (EVs) is delaying progress in the field, especially research using non-model organisms. To develop effective options for the detection of EVs, we explored glycolipid-based and protein-based markers. In this study, we show that cholera toxin subunit B (CTxb), which targets the glycosphingolipid GM1 in vertebrates, also binds to EVs from various non-model organisms enabling detection. However, whilst CTxb selectively detect EVs from cell culture and parasite media, it is unsuitable for complex biofluids, such as serum and plasma due to cross-reactivity with high- and low-density lipoproteins. Additionally, we show that the universally conserved glycolytic enzyme enolase is found in EVs from phylogenetically distant species. Multiple highly conserved regions exist across human and several representative non-model organism orthologues, enabling detection of EVs from non-model organism using antibodies against human enolase. Furthermore, the conserved enzymatic activity of enolase enables detection of EVs using an enzymatic assay. Together CTxb and enolase provide a tandem approach for detection of EVs from non-model organisms by targeting different, conserved components of EVs.
No takes yet. Share an insight, caveat, or question.
Zippor et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: